Canada markets close in 2 hours 31 minutes

FibroGen, Inc. (FGEN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.1400+0.0500 (+4.59%)
As of 01:28PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 108.43M
Enterprise Value 25.39M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.72
Price/Book (mrq)N/A
Enterprise Value/Revenue 0.17
Enterprise Value/EBITDA -0.10

Trading Information

Stock Price History

Beta (5Y Monthly) 0.74
52-Week Change 3-93.23%
S&P500 52-Week Change 324.19%
52 Week High 319.4700
52 Week Low 30.3330
50-Day Moving Average 31.7785
200-Day Moving Average 31.2451

Share Statistics

Avg Vol (3 month) 32.29M
Avg Vol (10 day) 31.19M
Shares Outstanding 598.77M
Implied Shares Outstanding 699.47M
Float 888.35M
% Held by Insiders 10.92%
% Held by Institutions 169.31%
Shares Short (Apr 15, 2024) 45.43M
Short Ratio (Apr 15, 2024) 42.72
Short % of Float (Apr 15, 2024) 47.23%
Short % of Shares Outstanding (Apr 15, 2024) 45.50%
Shares Short (prior month Mar 15, 2024) 45.53M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -192.37%
Operating Margin (ttm)-381.26%

Management Effectiveness

Return on Assets (ttm)-35.54%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)147.75M
Revenue Per Share (ttm)1.52
Quarterly Revenue Growth (yoy)-21.00%
Gross Profit (ttm)N/A
EBITDA -283.92M
Net Income Avi to Common (ttm)-284.23M
Diluted EPS (ttm)-2.9200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)235.59M
Total Cash Per Share (mrq)2.38
Total Debt (mrq)170.46M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.52
Book Value Per Share (mrq)-2.07

Cash Flow Statement

Operating Cash Flow (ttm)-315.02M
Levered Free Cash Flow (ttm)-220.02M